Drugs / Equimolar Oxygen-Nitrogen Protoxide Mix
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03638921 | Oct 2018 → Jun 2019 | urinary tract obstruction | Rennes University Hospital | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Equimolar Oxygen-Nitrogen Protoxide Mix | “MEOPA (Equimolar Oxygen-Nitrogen Protoxide Mix) is a gas used in emergencies for short-term painful acts.” NCT03638921 ↗ |
| Known as | MEOPA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03638921 ↗ |
| Modality | Other / unclassified | “MEOPA (Equimolar Oxygen-Nitrogen Protoxide Mix) is a gas used in emergencies for short-term painful acts.” NCT03638921 ↗ |
| Route | Inhaled | “Patients included in the study will receive MEOPA with a high concentration mask” NCT03638921 ↗ |